1. Ahmed F. AlDomairy MD. Histological and Ultrastructural Study of the Effect of Nandrolone on the Testis of Adult Male Albino Rat. Journal of American Science. 2013; 35(11):102-9.
2. Foss GL. Some experiences with a new anabolic steroid (methandrostenolone). Br Med J 2012; 1(5182):1300–1305.
3. Llewelynn W.Dianabol (methandrostenolone, methandienone). In: Llewelynn W (ed) Anabolics, 9th edn. Jupiter, Florida, 2009; 9: 207–211.
4. Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med. Sci. Sports Exerc 2004; 26:408-13.
5. Karbalay-Doust S, Noorafshan A, Ardekani FM, Mirkhani H. The reversibility of sperm quality after discontinuing nandrolone decanoate in adult male rats. Asian J. Androl 2010; 9(2):235-9.
6. Lewis MI, Horvitz GD, Clemmons DR, Fournier M. Role of IGF-I and IGFbinding proteins within diaphragm muscle in modulating the effects of nandrolone. Am. J. Physiol. Endocrinol. Metab 2012; 282(2):483-90.
7. Louis E, Raue U, Yang Y, Jemiolo B, Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 2009; 103(5):1744–1751.
8. Doaaz N, ChicoJuan J, Cabrera B, Octavio P. Luzardo. Evaluation of acute and chroni hepatotoxic effects exertedby anabolic – androgenic steroid stanozolol in adult male rats Organ Toxic Ity and Mechansims 2011; 23(10): 472 -465.
9. Noorafshan A, Karbalay-Doust S, Ardekani FM. High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in rats. Acta Pathologica Microbiologica et Immunologica Scandinavica 2012; 113(2):122-5.
10. Parr MK, Flenker U, Schänzer W. Sports-related issues and biochemistry of natural and synthetic anabolic substances. Endocrinol Metab Clin North Am 2012; 39(1):45–57.
11. Forbes D, Jackman M, Bishop A, Thomas M, Kambadur R, Sharma M. Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol 2013; 206:264–272.
12. Aoki MS, Soares AG, Miyabara EH, Baptista IL, Moriscot AS. Expression of genes related to myostatin signaling during rat skeletal muscle longitudinal growth. Muscle Nerve 2010; 40(6):992–999.
13. Boada LD, Zumbado M, Torres S, Lopez A, Diaz-Chico BN, Cabrera JJ, et al. Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats. Arch Toxicol 2009; 73:465–472.
14. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2010; 420:418–421.
15. Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 2010; 19(6):543–549.
16. Mohammed HH, Badawi ME, El-Tarabany MS, Rania M. Effects of boldenone undecylenate on growth performance, maintenance behavior, reproductive hormones and carcass traits of growing rabbits. Pol J Vet Sci. 2016; 19(2):245-51
17. Chen Y, Lebrun JJ, Vale W. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci USA 2011; 93:12992–12997.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 2012; 162(1):156–159.
19. De Souza R A, Gonçalves W, Cavalcante WLG, Pai-Silva MD, Gallacci M. Nandrolone stimulates MyoD expression during muscle regeneration in the condition of myonecrosis induced by Bothrops jararacussu venom poisoning. J Toxicol Environ Health 2011; 73:934–943.
20. Desaulles PA, Kraehenbuehl C, Schuler W, Bein HJ. Experimental study of dianabol, a new anabolic agent. 17 alpha-Methyl-17 beta-hydroxy-androstane-1, 4-diene-3-one. Schweiz Med Wochenschr 2010; 89:1313–1318.
21. Diel P, Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, et al. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol Lett 2011; 169(1):64–71.
22. Diel P, Schiffer T, Geisler S, Hertrampf T, Mosler S, Schulz S, et al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR. Mol Cell Endocrinol 2011; 330(1–2):1–9.
23. Eriksson A, Kadi F, Malm C, Thornell LE. Skeletal muscle morphology in power-lifters with and without anabolic steroids. Histochem Cell Biol 2010; 124(2):167–175.
24. Feraudi M, Weicker H. Effects of training and methandrostenolone (an anabolic steroid) on energy metabolism in the guinea pig: changes in enzyme activities in gastrocnemius muscle and myocardium. Int J Biochem 2011; 17(11):1191–1205.
25. Mosler S, Pankratz C, Seyfried A, Piechotta M, Diel P. The anabolic steroid methandienone targets the hypothalamic-pituitary-testicular axis and myostatin signaling in a rat training model. Arch Toxicol 2012 Jan; 86(1):109-19.
26. Cavalari FC, de Castro AL, Fracasso Bde M, Loss Eda S . Non-classic androgen actions in Sertoli cell membrane in whole seminiferous tubules: effects of nandrolone Decanoate and catechin. Steroids 2012; 77(1-2):118-25.
27. Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, et al. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicol Lett 2010; 164(1):16–23.
28. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab. 2012; 283(1):E154–E164.
29. Chaves EA, Pereira-Junior PP, Fortunato RS, Masuda MO, de Carvalho AC, de Carvalho DP, et al. Nandrolone decanoate impairs exercise-induced cadioprotection: Role of antioxidant enzymes. J Steroid Biochem Mol Biol 2006; 99(4-5): 223-30.
30. Lundholm L, Käll K, Wallin S, Thiblin I. Use of anabolic androgenic steroids in substance abusers arrested for cecebellum tisso:Drug and Alcohol Dependence 2010; 111,222-226.
31. Matsakas A, Friedel A, Hertrampf T, Diel P. Short-term endurance training results in a brain-specific decrease of myostatin mRNA content in the rat. Acta Physiol Scand 2011; 183:299–307.
32. Wheeler GD, Singh M, Pierce WD, Epling WF, Cumming DC. Endurance training decreases serum testosterone levels in rat without change in luteinizing hormone pulsatile release. J Clin Endocrinol Metab. 2013; 72(2):422–425.
33. Yesalis CE. Kennedy NJ. Kopstein AN, Bahrke MS. Anabolic – androgenic steroid use in the United States”. Journal of American veterinary medical association 2003; 270(8): 1217-1221.
34. Roselli CE. The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area. Brain Res 2013; 792(2):271–276.
35. Takahashi M, Tatsugi Y, Kohno T. Endocrinological and pathological effects of anabolic-androgenic steroid in male rats. Endocr J 2014; 51(4):425–434.
36. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2014; 300:965–967.
37. Wynn V, Landon J. A study of the androgenic and some related effects of methandienone. Br Med J 2014; 1:998–1003.
38. Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Kömen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2013; 350(26):2682–2688.
39. Steele RE, Didato F, Steinetz BG. Relative importance of 5alpha reduction for the androgenic and LH-inhibiting activities of delta-4-3-ketosteroids. Steroids 2011; 29(3):331–348.
40. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2014; 36(4):574–582.
)